XPO1 and laryngeal carcinoma: The results strengthen the idea that CRM1 gene expression level may be an important risk factor for the clinical stage of the tumor, lymph node involvement, and distant metastasis in laryngeal cancer patients and may have a prognostic value in the clinic [16–18,35].